AMASS Brands Secures 15.67% Stake in Afterdream via SAFE Investment
AMSS•AMASS Brands Group has invested in Afterdream via a SAFE instrument granting it at least a 15.67% ownership interest upon a qualifying financing event. Afterdream, a hemp-derived THC beverage available in seven states, has reported 43% gross sales growth over 90 days and 66% returning customer rate in May 2026.
1. Investment Details
AMASS Brands Group entered a SAFE for future equity granting it rights to at least 15.67% of Afterdream on a fully diluted basis upon a qualifying financing or liquidity event. The SAFE carries no interest, maturity date, or dilution prior to conversion and includes liquidation preferences senior to common stockholders.
2. Afterdream Brand Metrics
Afterdream is distributed in seven states and features a blend of hemp-derived THC, organic lion’s mane mushrooms, and L-Theanine. The brand achieved 43% gross sales growth in the last 90 days, a 66% returning customer rate in May 2026, and is available in over 100 on- and off-premise wholesale accounts.
3. Market Opportunity
The hemp-derived THC beverage category topped $1.1 billion in U.S. sales in 2024, while the functional relaxation segment is projected to grow from $495 million in 2024 to $2.1 billion by 2034. AMASS aims to capitalize on these trends through its strategic investment in Afterdream.
4. Strategic Rationale
AMASS sees Afterdream as a core addition to its multi-category beverage platform spanning non-alcohol, functional, and alcohol 2.0 products. The company retains the option to increase its ownership stake as regulations evolve, positioning it to scale the brand within a high-growth segment.
